Tweet
GENELABS TECHNOLOGIES, INC. - FINANCIAL AND STRATEGIC ANALYSIS REVIEW - NEW MARKET REPORT JUST PUBLISHED
PR-Inside.com (Pressemitteilung)
companiesandmarkets.com
2009-08 -10 17:45:02
Genelabs Technologies, Inc. - Financial and Strategic Analysis Review -
a new market research report on companiesandmarkets.com
www.companiesandmarkets.c om/Summary-Company-Profile/genelabs-tec ..
Genelabs Technologies, Inc. (Genelabs) is a biopharmaceutical company
engaged in discovering and developing pharmaceutical products to
improve human health. The company focuses on discovering novel
compounds that reduce replication of the hepatitis C virus and in
developing a late-stage product for lupus. The company mainly operates
in Armenia, Australia, New Zealand, and United States. As on January
7, 2009,
the company was aqcuired by GlaxoSmithKline, plc. The company is
headquartered at Redwood City of California in the US Genelabs
Technologies, Inc. - Financial and Strategic Analysis Review is
an in-depth business, strategic and financial analysis of Genelabs
Technologies, Inc.. The report provides a comprehensive insight into
the company, including business structure and operations, executive
biographies and key competitors. The hallmark of the report is the
detailed strategic analysis of the company. This highlights its
strengths and weaknesses and the opportunities and threats it faces
going forward.
Scope - Provides key company information for business intelligence
needs.
- The company's strengths and weaknesses and areas of development or
decline are analyzed. Financial, strategic and operational factors
are considered.
- The opportunities open to the company are considered and its
growth potential assessed. Competitive or technological threats
are highlighted.
- The report contains critical company information - business structure
and operations, the company history, major products and services,
key competitors, key employees and executive biographies, different
locations and important subsidiaries.
- The report provides detailed financial ratios for the past five
years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns,
liquidity and leverage, financial position and efficiency ratios.
Reasons to buy - A quick ""one-stop-shop"" to understand the company.
- Enhance business/sales activities by understanding customers'
businesses better.
- Get detailed information and financial and strategic analysis on
companies operating in your industry.
- Identify prospective partners and suppliers - with key data on
their businesses and locations.
- Capitalize on competitors weaknesses and target the market
opportunities available to them.
- Compare your company's financial trends with those of your peers
/ competitors.
- Scout for potential acquisition targets, with detailed insight into
the companies' strategic, financial and operational performance.
From: Emil Lazarian | Ararat NewsPress
PR-Inside.com (Pressemitteilung)
companiesandmarkets.com
2009-08 -10 17:45:02
Genelabs Technologies, Inc. - Financial and Strategic Analysis Review -
a new market research report on companiesandmarkets.com
www.companiesandmarkets.c om/Summary-Company-Profile/genelabs-tec ..
Genelabs Technologies, Inc. (Genelabs) is a biopharmaceutical company
engaged in discovering and developing pharmaceutical products to
improve human health. The company focuses on discovering novel
compounds that reduce replication of the hepatitis C virus and in
developing a late-stage product for lupus. The company mainly operates
in Armenia, Australia, New Zealand, and United States. As on January
7, 2009,
the company was aqcuired by GlaxoSmithKline, plc. The company is
headquartered at Redwood City of California in the US Genelabs
Technologies, Inc. - Financial and Strategic Analysis Review is
an in-depth business, strategic and financial analysis of Genelabs
Technologies, Inc.. The report provides a comprehensive insight into
the company, including business structure and operations, executive
biographies and key competitors. The hallmark of the report is the
detailed strategic analysis of the company. This highlights its
strengths and weaknesses and the opportunities and threats it faces
going forward.
Scope - Provides key company information for business intelligence
needs.
- The company's strengths and weaknesses and areas of development or
decline are analyzed. Financial, strategic and operational factors
are considered.
- The opportunities open to the company are considered and its
growth potential assessed. Competitive or technological threats
are highlighted.
- The report contains critical company information - business structure
and operations, the company history, major products and services,
key competitors, key employees and executive biographies, different
locations and important subsidiaries.
- The report provides detailed financial ratios for the past five
years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns,
liquidity and leverage, financial position and efficiency ratios.
Reasons to buy - A quick ""one-stop-shop"" to understand the company.
- Enhance business/sales activities by understanding customers'
businesses better.
- Get detailed information and financial and strategic analysis on
companies operating in your industry.
- Identify prospective partners and suppliers - with key data on
their businesses and locations.
- Capitalize on competitors weaknesses and target the market
opportunities available to them.
- Compare your company's financial trends with those of your peers
/ competitors.
- Scout for potential acquisition targets, with detailed insight into
the companies' strategic, financial and operational performance.
From: Emil Lazarian | Ararat NewsPress